| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |